ARCA biopharma, Inc.
METHODS AND COMPOSITIONS INVOLVING BUCINDOLOL FOR THE TREATMENT OF ATRIAL FIBRILLATION
Last updated:
Abstract:
The current methods and compositions relate to treatment of atrial fibrillation with bucindolol in patients, including patients with heart failure, after being determined to be homozygous Arg389 in the .beta..sub.1 adrenergic receptor gene.
Status:
Application
Type:
Utility
Filling date:
8 Feb 2021
Issue date:
19 Aug 2021